ZTEK Zentek Limited: Market Value to Book Value Ratio

Corporate emblem and logo of Zentek Limited (ZTEK)

Zentek Ltd. (ZTEK) is protected by exclusive patents for antibacterial graphene layers and biotech sector support under strict FDA oversight. The price chart on GURU.Markets, where the indicator stands at 3.52, complements data regarding management's strategy to bring innovative nanomaterials to market. The technological complexity of compound synthesis creates a powerful moat, separating the company from traditional medical device manufacturers.

Zentek Corp (ZTEK) - Market-to-Book Ratio from 04/28/2023 to 09/12/2026
Flagship merchandise of Zentek Ltd

Zentek Ltd. (ZTEK) expansion into the ZenGuard antimicrobial coatings sector is driving expectations for future asset value growth. The historical relationship between market capitalization and book value demonstrates a market premium over the company's net assets. This indicator is calculated by dividing the current market value of all shares by the book value of equity. This trend captures investor confidence in the scaling of the company's B2B contracts. The analysis allows for the determination of the degree of business overvaluation relative to its tangible asset base.

Competitor analysis

Intuitive Surgical (ISRG) - Market Value to Book Value Ratio|danaher.com (DHR) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Becton Dickinson|Market Cap to Net Assets Ratio STERIS PLC (STE)|Market Capitalization to Book Value Ratio WST|BAX - Market-to-Book Ratio|Market Capitalization to Book Value Ratio MASI (Masimo Corporation)|STVN: Capitalization to Book Value Ratio|Teleflex - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Merit Medical Systems, Inc. MMSI|NVST: Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio ICU Medical Inc.|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio lemaitre.com|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAA (STAAR Surgical Co.)|niagenbioscience.com - Market Cap to Net Assets Ratio|Market Value to Book Value ZIMV|AngioDynamics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value cerus.com CERS|Teknova (TKNO) - Market Value to Book Value Ratio|Capitalization to Book Value Ratio MGRM|Market Value to Book Value Ratio Sharps Technology Inc|InfuSystem Inc (INFU) - Market Capitalization to Book Value|Market Cap to Net Assets Ratio UTMD (Utah Medical Products)|Market Cap to Book Value Multiple KRMD|Market Value to Book Value Ratio Nyxoah NYXH|Market Value to Book Value MBOT|PDEX: Market Cap to Net Assets Ratio|ELUT - Market Capitalization to Book Value Ratio|Milestone Scientific (MLSS) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio nexgel.com|RVP (Retractable Technologies Inc.) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Harvard Bioscience Inc. HBIO|Market Value to Book Value Ratio Femasys Corp (FEMY)|meihuamed.com - Capitalization to Book Value Ratio|Predictive Oncology Inc. - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple CJMB (Callan JMB Inc.)|ATRI - Market Value to Book Value Ratio|Market Capitalization to Book Value NeuroMetrix Inc NURO